Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Sarcoma
•
Medical Oncology
•
Cancer of Unknown Primary
How would you treat someone with unknown primary metastatic SMARCA4 deficient tumor (high-grade tumor with rhabdoid morphology)?
Answer from: Medical Oncologist at Community Practice
Ponatinib might be useful. You might also see if a clinical trial is available.http://clincancerres.aacrjournals.org/content/24/8/1932
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
Consider tazemetostat (epigenetic modifier via EZH2 nhibition) via compassionate use program.
Sign in or Register to read more
5664
5676
Related Questions
Would you offer adjuvant systemic therapy for recurrent fallopian tube leiomyosarcoma after resection of an isolated liver metastasis that presented within 1 year from primary surgery?
How do you approach a young patient with undifferentiated pleomorphic sarcoma of the upper extremity who developed ifosfamide-induced nephrotoxicity after two cycles of adjuvant AIM chemotherapy?
Would you recommend post operative radiation in an adult patient with a thoracic spine osteosarcoma?
How do you approach a patient with undifferentiated pleomorphic sarcoma encasing the spinal cord post radiation for neurological deficits for further management?
How do you approach patients with osteosarcoma of the maxilla for neoadjuvant chemotherapy?
How do you approach patients with SDH deficient advanced GIST tumor for systemic treatment?
How do you sequence treatment for a patient following R2 resection of a large extremity leiomyosarcoma who has small lung nodules concerning for metastatic disease, but not yet biopsy proven?
Would you use neoadjuvant TKI or neoadjuvant radiation for a large chest wall sarcoma with an NTRK fusion on NGS?
How do you approach patients with lymph node positive osteosarcoma of the extremities for neoadjuvant chemotherapy?
How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?